Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Shattock: Novel Antigens for Mucosal Protection |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2009-11-13 |
| Study Made Public: | 2011-09-30 |
Title
Neutralization activity of sera collected from rabbits immunized with two types of recombinant clade C HIV gp140, formulated with two types of novel adjuvant, by the intradermal route.
Description
CAVD 305 is a preclinical rabbit study comparing protein and adjuvant regimens administered by the intradermal route.
Sign in to see full information about this study and to download study data.
Products
PEI CN54env-gp140 ZM96 gp140 Wax particlesIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.